receive daily
reports of the
TOP PICKS
OR
your personal
stock choices
| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
|
| There are 4 registered members and 76 guests viewing the site. | Follow us on Twitter |  Rss Top Picks Feed | Rss Daily Feed |
|
| Comment | 2.410 | Peter Hodson | Phase 2 cancer company with some pretty decent results. They are a long way away from where they want to be. Product has huge potential. | 2007-02-19 | |
| WEAK BUY | 7.250 | Peter Hodson | Not aware of any upcoming short term catalysts. Continuing with their trials. Never had bad results. Very volatile and still early stage. | 2004-09-24 | |
| WAIT | 7.150 | Peter Hodson | Has a pretty high beta, so the stock goes up and down like a yo-yo. Likes with the company is doing. At some point, a major pharmaceutical company will get interested in their technology. Would like to see more trials and results. | 2004-07-08 | |
| DON'T BUY | 3.490 | Peter Hodson | If they can find the right deals and get through the clinical trials, the upside would be phenomenal. Very volatile right now. | 2003-09-09 | |
| WEAK BUY | 3.250 | Peter Hodson | A wild stock. Created a virus that could reduce cancer dramatically. Long term potential could be good. Trials have only been small ones. Risky. | 2003-07-10 | |
| WEAK BUY | 4.000 | John Sinkins, CFA | Biotechs have had good moves. Has a ways to go before their drug is on the market. Speculative in the short term. | 2003-06-02 | |
| WEAK BUY | 2.550 | Peter Hodson | Interesting technology. Trials are turning out well, but too small a sampling at this time. Speculative. | 2003-05-06 |
